Searchable abstracts of presentations at key conferences in endocrinology

ea0056p1141 | Thyroid cancer | ECE2018

Medullary thyroid carcinoma: a case report on the efficacy and safety of combined treatment with Vandetanib and Lanreotide Autogel

Kalantzi Athanasia , Papanastasiou Labrini , Charalabidou Liana , Lyberopoulos Konstantinos , Kounadi Theodora

Introduction: Treatment options for progressive metastatic unresectable medullary thyroid carcinoma (MTC) include tyrosine kinase inhibitors (TKIs) or somatostatin analogues (SSA), although the efficacy of the latter is debatable. In such cases, combined treatment of TKIs and SSAs has not previously been reported.Aim: To present a metastatic MTC case successfully treated with a combination of Vandetanib and Lanreotide Autogel.Case ...